Cargando…
Treatment of T-Cell Prolymphocytic Leukemia with Central Nervous System Involvement Using Intrathecal Alemtuzumab Administration
T-cell prolymphocytic leukemia (T-PLL) is a rare hematologic cancer with a dismal prognosis. Although a small number of patients have central nervous system (CNS) involvement, a standard treatment approach for these patients has not been established. Herein, we present a case of T-PLL with CNS invol...
Autores principales: | Mori, Jinichi, Oshima, Kumi, Kimura, Satoshi, Ikezoe, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403948/ https://www.ncbi.nlm.nih.gov/pubmed/32802528 http://dx.doi.org/10.1155/2020/8822172 |
Ejemplares similares
-
Rhodococcus equi Infection after Alemtuzumab Therapy for T-cell Prolymphocytic Leukemia
por: Meeuse, Jan J., et al.
Publicado: (2007) -
Central Nervous System Involvement of T-cell Prolymphocytic Leukemia Diagnosed with Stereotactic Brain Biopsy: Case Report
por: Göçmen, Selçuk, et al.
Publicado: (2014) -
P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL)
por: Kadia, T., et al.
Publicado: (2022) -
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report
por: Okada, Naoki, et al.
Publicado: (2023) -
T-cell Prolymphocytic Leukemia with Cutaneous Involvement as the Presenting Feature
por: Ashturkar, Amrut V, et al.
Publicado: (2012)